Ally Anderson Alveolar Rhabdomyosarcoma (ARMS) Research Fund
Fighting ARMS and All Childhood Cancers in Honor of Ally Anderson
The Ally Anderson Alveolar Rhabdomyosarcoma Research Fund has been established in honor of childhood cancer fighter Ally Anderson from Ohio. The goal is to raise research funds through the Arms Wide Open Childhood Cancer Foundation to help find safer and less-toxic treatments for Alveolar Rhabdomyosarcoma.
Ally says, “Five years ago, on September 5, 2018, I heard the dreaded words, ‘You have cancer’ and since then, I have heard those words an additional 5 times making this the 6th fight for my life…At 16 years old, I have been forced to think about my life and the end more than a kid should have to. This is why we need more funding for research. I feel that kids should not be faced with life-or-death situations. I believe that we can help raise money to fight cancer. Knowing and learning about cancer is important because it could be anyone. I thought it could never be me until it was, and I quickly realized how common it is. It shouldn’t take a diagnosis of you or someone you love to get involved.”
At Ally's request, the initial funding will support promising research by Oncoheroes. Focused entirely on developing new therapies for children with cancer, Oncoheroes is partnering with Hopp Children's Cancer Center Heidelberg" (KiTZ) to test Oncoheroes' lead compound, Volasertib, with the hope of finding signs of efficacy in several types of pediatric cancers, including Rhabdomyosarcoma. This basket trial, largely supported by Ein Herz für Kinder, would be the first comprehensive pediatric evaluation of this promising compound and would serve as the basis for a later global registration trial in the most suitable pediatric indication.
Please consider a donation to the Ally Anderson Alveolar Rhabdomyosarcoma Research Fund to honor Ally.